Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Veterinary Generics Market: By Product Type, By Animal Type Swine, Bovine, Horses, Others), By End Users, and Geography
Veterinary Generics Market: By Product Type, By Animal Type Swine, Bovine, Horses, Others), By End Users, and Geography
Veterinary Generics Market size was valued at US$ 46.32 billion in 2023 and is poised to grow at a significant CAGR of 6.5% from 2024 - 2030 anticipated to offer potential growth opportunities for the market players over the forecast period. Rapid evolutions of generic molecules with similar therapeutic activity, and the cost-effectiveness of the products are enabling to attract customers towards the veterinary generics. The active pharmaceutical ingredient (API) of the generic molecule must be bioequivalent to the patented product. Veterinary pharma companies are focused on producing generic molecules to meet the unmet need in the market. Increased adoption of small animals such as dogs and cats has been trending for the past few years. The rise in the prevalence of various diseases like osteoarthritis (OA), chronic cancer pain, inflammation, and other skin allergies is expected to create demand for the veterinary generics market.
The generic products cost less than the branded products, so the cost of the treatment will be reduced. This enables a greater margin on the farm with the same desired effects and ensures good welfare standards. The introduction of generic products can increase the competition within the market for that active ingredient, less cost of the product making it more affordable to the end user. Increased veterinary hospitals and clinics to offer better services to small animals, as well as farm animals, are anticipated to witness significant growth in the veterinary generics market. The introduction of new generic drugs to treat chronic and acute pain, inflammation, and other diseases is creating healthy growth opportunities. Rise in mergers & acquisitions to offer affordable products, can offer novel analgesics to the market. Increased awareness among veterinary specialists and the introduction of generic drugs are anticipated to create lucrative opportunities over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
6.8%Largest Market
North-AmericaFastest Growing Market
North America
Increasing farm animal and poultry industry across the globe is expected to create the demand for veterinary generics market. Favorable government policies to enhance the farm animal production create awareness about various diseases and treatment methods are expected to create demand for veterinary market over the forecast period. Furthermore, increased awareness regarding veterinary generic drugs among veterinary professionals is expected to fuel market.
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. U.S. veterinary generics market is expected to account for major market share over the forecast time frame due to increased pet adoption and raising awareness among pet lovers regarding the animal health and various treatment options in the country. Europe veterinary generics market is expected witness for robust growth rate over the forecast period. Germany veterinary generics market is anticipated to dominate the regional market share due to increased demand for meat and other protein-rich food. Moreover, increased awareness is creating growth opportunities for the market players. China veterinary generics market is accounted for the major market share in Asia Pacific, due to rising population and increased demand for food are major drivers of the market. India market is expanding at significant CAGR over the forecast period. Rising disposable income coupled with rising veterinary healthcare facilities, increasing adoption of small animals such as cats and dogs are expected to accelerate the market size. Latin America veterinary generics market is led by Brazil, is witnessing to grow at unprecedented CAGR over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 46.32 billion |
|
Market CAGR |
6.8% |
|
By Product Type |
|
|
By Animal Type |
|
|
By End User |
|
Download Free Sample Report
The veterinary generics market size was valued at US$ 46.32 billion in 2023
The veterinary generics market key players are Zoetis Inc. Elanco Merial Bayer Animal Health Virbac S.A. IDEXX Laboratories Boehringer Ingelheim Vetmedica Ceva Sante Animale Vetoquinol S.A.
The veterinary generics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Veterinary Generics Market Introduction |
| 2.1.Global Veterinary Generics Market - Taxonomy |
| 2.2.Global Veterinary Generics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Animal Type |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Veterinary Generics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Veterinary Generics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Veterinary Generics Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Antibiotics |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. NSAIDS |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Veterinary antifungal drugs |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Veterinary antihelminthics |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Veterinary biologics |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Veterinary Generics Market By Animal Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Small pets |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Swine |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Bovine |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Horses |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Veterinary Generics Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Veterinary hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Veterinary clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Veterinary Generics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Veterinary Generics Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Antibiotics |
| 9.1.2.NSAIDS |
| 9.1.3.Veterinary antifungal drugs |
| 9.1.4.Veterinary antihelminthics |
| 9.1.5.Veterinary biologics |
| 9.2. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Small pets |
| 9.2.2.Swine |
| 9.2.3.Bovine |
| 9.2.4.Horses |
| 9.2.5.Others |
| 9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Veterinary hospitals |
| 9.3.2.Veterinary clinics |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Veterinary Generics Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Antibiotics |
| 10.1.2.NSAIDS |
| 10.1.3.Veterinary antifungal drugs |
| 10.1.4.Veterinary antihelminthics |
| 10.1.5.Veterinary biologics |
| 10.2. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Small pets |
| 10.2.2.Swine |
| 10.2.3.Bovine |
| 10.2.4.Horses |
| 10.2.5.Others |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Veterinary hospitals |
| 10.3.2.Veterinary clinics |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Veterinary Generics Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Antibiotics |
| 11.1.2.NSAIDS |
| 11.1.3.Veterinary antifungal drugs |
| 11.1.4.Veterinary antihelminthics |
| 11.1.5.Veterinary biologics |
| 11.2. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Small pets |
| 11.2.2.Swine |
| 11.2.3.Bovine |
| 11.2.4.Horses |
| 11.2.5.Others |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Veterinary hospitals |
| 11.3.2.Veterinary clinics |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Veterinary Generics Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Antibiotics |
| 12.1.2.NSAIDS |
| 12.1.3.Veterinary antifungal drugs |
| 12.1.4.Veterinary antihelminthics |
| 12.1.5.Veterinary biologics |
| 12.2. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Small pets |
| 12.2.2.Swine |
| 12.2.3.Bovine |
| 12.2.4.Horses |
| 12.2.5.Others |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Veterinary hospitals |
| 12.3.2.Veterinary clinics |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Veterinary Generics Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Antibiotics |
| 13.1.2.NSAIDS |
| 13.1.3.Veterinary antifungal drugs |
| 13.1.4.Veterinary antihelminthics |
| 13.1.5.Veterinary biologics |
| 13.2. Animal Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Small pets |
| 13.2.2.Swine |
| 13.2.3.Bovine |
| 13.2.4.Horses |
| 13.2.5.Others |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Veterinary hospitals |
| 13.3.2.Veterinary clinics |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis Inc. |
| 14.2.2.Elanco |
| 14.2.3.Merial |
| 14.2.4.Bayer Animal Health |
| 14.2.5.Virbac S.A. |
| 14.2.6.IDEXX Laboratories |
| 14.2.7.Boehringer Ingelheim Vetmedica |
| 14.2.8.Ceva Sante Animale |
| 14.2.9.Vetoquinol S.A. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.